Plant-based Vaccines Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Vaccine Type (Bacterial Vaccines, Viral Vaccines, Parasite Vaccines, Others); Source (Tobacco Plant, Maize, Potato, Others); Application (Influenza, Zika Virus, Ebola Virus, Poultry Disease, Others) and Geography
Publication Month: Nov 2021 | Report Code: TIPRE00024327 | No. of Pages: 243 | Category: Pharmaceuticals | Status: Published
The plant-based vaccines market is expected to reach US$ 2,672.05 million by 2028 from US$ 1,143.72 million in 2021. The market is estimated to grow at a CAGR of 12.9 % from 2021 to 2028.
The scope of the plant-based vaccines market includes vaccine type, source, application, and geography. Based on region, the plant-based vaccines market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South and Central America. The report offers insights and in-depth analysis of the plant-based vaccines market, emphasizing various parameters such as market trends and opportunities, market dynamics, and competitive landscape analysis of leading market players across North America, Europe, Asia Pacific, Middle East & Africa, and South and Central America. It also includes COVID–19 impact analysis across the regions.
Strategic Insights
Lucrative Regions for Plant-Based Vaccines Market
Get more information on this report :
Market Insights
Increasing Number of Research & Development (R&D) Activities in Plant-Based Vaccines
The lack of vaccines to prevent fatal diseases has created issues and prompted a worldwide focus on the development of safer, easier, and more effective vaccines. Plants are among the world's most prolific protein creators. Plants efficiently express proteins of various complexity and glycosylation patterns. Recombinant technology is used to create plant-derived vaccines, in which the gene encoding the required antigen protein is incorporated into the plant genome. Furthermore, experts estimate that the production of a plant-based vaccine takes five to six weeks instead of the five to six months required by vaccine makers to prepare the vaccine in chicken eggs. Many countries worldwide are developing an effective vaccine to combat the spread of COVID-19, and plant-based vaccines are one of the options for vaccine development. Plant-based vaccines have a good reputation among researchers because of their well-known successful manufacturing procedure and low cost. Various research and clinical trials are carried out for the development of plant-based vaccines. For instance, Medicago Inc. a clinical-stage biotechnology company that uses plant-based technologies to develop and produce novel vaccines and antibodies had successfully produced virus-like particles (VLPs) of the novel coronavirus just 20 days after obtaining the SARS-CoV-2 gene (the virus causing the COVID-19 disease). Existing prominent players and new entrants in the plant-based vaccines market are concentrating their efforts on conducting comprehensive clinical trials to produce plant-based vaccines for a variety of therapeutic applications. Hence, the increasing number of Research & Development (R&D) activities in plant-based vaccines will surge the demand for plant-based vaccines substantially across the world, leading to an upward thrust in the market's growth.
Vaccine Type-Based Insights
Based on vaccine type, the plant-based vaccines market is segmented into bacterial vaccines, viral vaccines, parasite vaccines, plant-derived virus-like particles (VLPS), and others. The bacterial vaccines segment held the largest share of the market in 2021. However, the plant-derived virus-like particles (VLPs) segment is anticipated to register the highest CAGR of 13.6% in the market during the forecast period.
Plant-Based Vaccines Market, by Vaccine Type – 2021 & 2028
Get more information on this report :
Source-Based Insights
Based on source, the plant-based vaccines market is segmented into tobacco plant, maize, potato, and others. The tobacco plant segment held the largest share of the market in 2021, and the same segment is anticipated to register the highest CAGR of 13.3% in the market during the forecast period.
Application-Based Insights
Based on application, the plant-based vaccines market is segmented into influenza, zika virus, Ebola virus, poultry disease, COVID-19, and others. The influenza segment held the largest share of the market in 2021. However, the COVID-19 segment is anticipated to register the highest CAGR of 13.8% in the market during the forecast period.
Companies commonly adopt inorganic strategies such as mergers and acquisitions to cater to changing customer demand and maintain their brand name worldwide. Market players operating in the plant-based vaccines market also adopt organic strategies such as product launch and expansion to outstretch their footprint and product portfolio worldwide and meet the growing demand.
By Vaccine Type
- Bacterial Vaccines
- Viral Vaccines
- Parasite Vaccines
- Plant-Derived Virus-Like Particles (VLPs)
- Others
By Source
- Tobacco Plant
- Maize
- Potato
- Others
By Application
- Influenza
- Zika Virus
- Ebola Virus
- COVID-19
- Poultry Disease
- Others
By Geography
- North America
- US
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East & Africa
- Saudi Arabia
- South Africa
- UAE
- Rest of Middle East & Africa
- South and Central America
- Brazil
- Argentina
- Rest of South and Central America
Company Profiles
- MEDICAGO, INC.
- British American Tobacco p.l.c.
- ICON GENETICS GMBH
- CREATIVE BIOLABS, INC.
- iBio, Inc.
- LENIOBIO
- Lumen Bioscience, Inc.
- LEAF EXPRESSION SYSTEMS LTD.
- ZYUS LIFE SCIENCES INC.
- FRAUNHOFER CMB
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Plant-based Vaccines Market – By Vaccine Type
1.3.2 Global Plant-based Vaccines Market – By Source
1.3.3 Global Plant-based Vaccines Market – By Application
1.3.4 Global Plant-based Vaccines Market – By Geography
2. Global Plant-based Vaccines Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Plant-based Vaccines Market– Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America – PEST Analysis
4.2.2 Europe – PEST Analysis
4.2.3 Asia Pacific – PEST Analysis
4.2.4 Middle East and Africa – PEST Analysis
4.2.5 South and Central America (SCAM) – PEST Analysis
4.3 Experts Opinion
5. Plant-based Vaccines Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Number of Research & Development (R&D) Activities in Plant-Based Vaccines
5.1.2 Growing Prevalence of Infectious Diseases
5.2 Market Restraints
5.2.1 Potential Risk of Contamination and Environmental Risks for Manufacturing Plant-Based Vaccines
5.3 Market Opportunities
5.3.1 Advancements in Production of Plant-Based Vaccines
5.4 Future Trends
5.4.1 Spur in Prevalence of Infectious Diseases and Increase in Product Approvals
5.5 Impact Analysis
6. Plant-based Vaccines Market– Global Analysis
6.1 Global Plant-based Vaccines Market Revenue Forecast and Analysis
6.2 Global Plant-based Vaccines Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players
7. Plant-Based Vaccines Market Analysis – By Vaccine Type
7.1 Overview
7.2 Plant-based Vaccines Market Revenue Share, by Vaccine Type (2021 and 2028)
7.3 Bacterial Vaccines
7.3.1 Overview
7.3.2 Bacterial Vaccines: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
7.4 Viral Vaccines
7.4.1 Overview
7.4.2 Viral Vaccines: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
7.5 Parasite Vaccines
7.5.1 Overview
7.5.2 Parasite Vaccines: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
7.6 Plant-derived Virus-like Particles (VLPs)
7.6.1 Overview
7.6.2 Plant-derived Virus-like particles (VLPs): Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
7.7 Others
7.7.1 Overview
7.7.2 Others: Plant-based Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
8. Plant-based Vaccines Market Analysis – By Source
8.1 Overview
8.2 Plant-based Vaccines Market Revenue Share, by Source (2021 and 2028)
8.3 Tobacco Plant
8.3.1 Overview
8.3.2 Tobacco Plant: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
8.4 Maize
8.4.1 Overview
8.4.2 Maize: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
8.5 Potato
8.5.1 Overview
8.5.2 Potato: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
8.6 Others
8.6.1 Overview
8.6.2 Others: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
9. Plant-based Vaccines Market Analysis– by Application
9.1 Overview
9.2 Plant-based Vaccines Market Revenue Share, by Application (2021 and 2028)
9.3 Influenza
9.3.1 Overview
9.3.2 Influenza: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
9.4 Zika Virus
9.4.1 Overview
9.4.2 Zika Virus: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
9.5 Ebola Virus
9.5.1 Overview
9.5.2 Ebola Virus: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
9.6 Poultry Disease
9.6.1 Overview
9.6.2 Poultry Disease: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
9.7 Covid-19
9.7.1 Overview
9.7.2 Covid-19: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
9.8 Others
9.8.1 Overview
9.8.2 Others: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
10. Plant-based Vaccines Market – Geographic Analysis
10.1 North America: Plant based vaccines Market
10.1.1 Overview
10.1.2 North America Plant-Based Vaccines Market - Revenue and Forecast to 2028 (USD Million)
10.1.3 North America Plant-Based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
10.1.4 North America Plant-Based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
10.1.5 North America Plant-Based Vaccines Market, by Application – Revenue and Forecast to 2028 (USD Million)
10.1.6 North America: Plant-Based Vaccines Market, by Country, 2021 & 2028 (%)
10.1.6.1 US: Plant-Based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.1.1 US: Plant-Based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.1.2 US Plant-Based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
10.1.6.1.3 US Plant-Based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
10.1.6.1.4 US Plant-Based Vaccines Market, by Application– Revenue and Forecast to 2028 (USD Million)
10.1.6.2 Canada: Plant-Based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.2.1 Canada: Plant-Based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.2.2 Canada Plant-Based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
10.1.6.2.3 Canada Plant-Based Vaccines Market, by Source– Revenue and Forecast to 2028 (USD Million)
10.1.6.2.4 Canada Plant-Based Vaccines Market, by Application– Revenue and Forecast to 2028 (USD Million)
10.1.6.3 Mexico: Plant-Based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.3.1 Mexico: Plant-Based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.3.2 Mexico Plant-Based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
10.1.6.3.3 Mexico Plant-Based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
10.1.6.3.4 Mexico Plant-Based Vaccines Market, by Application– Revenue and Forecast to 2028 (USD Million)
10.2 Europe: Plant-based Vaccines Market
10.2.1 Overview
10.2.2 Europe: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
10.2.3 Europe: Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
10.2.4 Europe: Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
10.2.5 Europe: Plant-based Vaccines Market, By Application – Revenue and Forecast to 2028 (USD Million)
10.2.6 Europe: Plant-based Vaccines Market, by Country, 2021 & 2028 (%)
10.2.6.1 Germany: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.1.1 Germany: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.1.2 Germany: Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
10.2.6.1.3 Germany: Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
10.2.6.1.4 Germany: Plant-based Vaccines Market, By Application– Revenue and Forecast to 2028 (USD Million)
10.2.6.2 France: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.2.1 France: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.2.2 France: Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
10.2.6.2.3 France: Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
10.2.6.2.4 France: Plant-based Vaccines Market, By Application– Revenue and Forecast to 2028 (USD Million)
10.2.6.3 UK: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.3.1 UK: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.3.2 UK: Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
10.2.6.3.3 UK: Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
10.2.6.3.4 UK: Plant-based Vaccines Market, By Application– Revenue and Forecast to 2028 (USD Million)
10.2.6.4 Italy: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.4.1 Italy: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.4.2 Italy: Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
10.2.6.4.3 Italy: Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
10.2.6.4.4 Italy: Plant-based Vaccines Market, By Application– Revenue and Forecast to 2028 (USD Million)
10.2.6.5 Spain: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.5.1 Spain: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.5.2 Spain: Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
10.2.6.5.3 Spain: Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
10.2.6.5.4 Spain: Plant-based Vaccines Market, By Application– Revenue and Forecast to 2028 (USD Million)
10.2.6.6 Rest of Europe: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.6.1 Rest of Europe: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.6.2 Rest of Europe: Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
10.2.6.6.3 Rest of Europe: Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
10.2.6.6.4 Rest of Europe: Plant-based Vaccines Market, By Application– Revenue and Forecast to 2028 (USD Million)
10.3 Asia Pacific: Plant-based Vaccines Market
10.3.1 Overview
10.3.2 Asia Pacific: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
10.3.3 Asia Pacific: Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
10.3.4 Asia Pacific: Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
10.3.5 Asia Pacific: Plant-based Vaccines Market, by Application – Revenue and Forecast to 2028 (USD Million)
10.3.6 Asia Pacific: Plant-based Vaccines Market, by Country, 2021 & 2028 (%)
10.3.6.1 China: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.1.1 China: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.1.2 China: Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
10.3.6.1.3 China: Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
10.3.6.1.4 China: Plant-based Vaccines Market, by Application – Revenue and Forecast to 2028 (USD Million)
10.3.6.2 Japan: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.2.1 Japan: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.2.2 Japan: Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
10.3.6.2.3 Japan: Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
10.3.6.2.4 Japan: Plant-based Vaccines Market, by Application – Revenue and Forecast to 2028 (USD Million)
10.3.6.3 India: Plant-based Vaccines Market - Revenue and Forecasts to 2028 (USD Million)
10.3.6.3.1 India: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.3.2 India: Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
10.3.6.3.3 India: Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
10.3.6.3.4 India: Plant-based Vaccines Market, by Application – Revenue and Forecast to 2028 (USD Million)
10.3.6.4 South Korea: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.4.1 South Korea: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.4.2 South Korea: Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
10.3.6.4.3 South Korea: Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
10.3.6.4.4 South Korea: Plant-based Vaccines Market, by Application – Revenue and Forecast to 2028 (USD Million)
10.3.6.5 Australia: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.5.1 Australia: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.5.2 Australia: Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
10.3.6.5.3 Australia: Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
10.3.6.5.4 Australia: Plant-based Vaccines Market, by Application – Revenue and Forecast to 2028 (USD Million)
10.3.6.6 Rest of Asia Pacific: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.6.1 Rest of Asia Pacific: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.6.2 Rest of Asia Pacific: Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
10.3.6.6.3 Rest of Asia Pacific: Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
10.3.6.6.4 Rest of Asia Pacific: Plant-based Vaccines Market, by Application – Revenue and Forecast to 2028 (USD Million)
10.4 South and Central America: Plant-Based Vaccines Market
10.4.1 Overview
10.4.2 South and Central America: Plant-Based Vaccines Market - Revenue and Forecast to 2028 (USD Million)
10.4.3 South and Central America Plant-Based Vaccines Market, By vaccine Type– Revenue and Forecast to 2028 (USD Million)
10.4.4 South and Central America Plant-Based Vaccines Market, By Source – Revenue and Forecast to 2028 (USD Million)
10.4.5 South and Central America Plant-Based Vaccines Market, By Application – Revenue and Forecast to 2028 (USD Million)
10.4.6 South and Central America: Plant-Based Vaccines Market Share by Country – 2021 & 2028, (%)
10.4.6.1 Brazil: Plant-Based Vaccines Market- Revenue and Forecasts To 2028 (USD Million)
10.4.6.1.1 Brazil: Plant-Based Vaccines Market- Revenue and Forecasts To 2028 (USD Million)
10.4.6.1.2 Brazil Plant-Based Vaccines Market, By Vaccine Type– Revenue and Forecast to 2028 (USD Million)
10.4.6.1.3 Brazil Plant-Based Vaccines Market, By Source – Revenue and Forecast to 2028 (USD Million)
10.4.6.1.4 Brazil Plant-Based Vaccines Market, By Application – Revenue and Forecast to 2028 (USD Million)
10.4.6.2 Argentina: Plant-Based Vaccines Market- Revenue and Forecasts To 2028 (USD Million)
10.4.6.2.1 Argentina: Plant-Based Vaccines Market- Revenue and Forecasts To 2028 (USD Million)
10.4.6.2.2 Argentina Plant-Based Vaccines Market, By Vaccine Type– Revenue and Forecast to 2028 (USD Million)
10.4.6.2.3 Argentina Plant-Based Vaccines Market, By Source – Revenue and Forecast to 2028 (USD Million)
10.4.6.2.4 Argentina Plant-Based Vaccines Market, By Application – Revenue and Forecast to 2028 (USD Million)
10.4.6.3 Rest of South and Central America: Plant-Based Vaccines Market - Revenue and Forecast to 2028 (USD Million)
10.4.6.3.1 Rest of South and Central America: Plant-Based Vaccines Market - Revenue and Forecast to 2028 (USD Million)
10.4.6.3.2 Rest of South and Central America Plant-Based Vaccines Market, By Vaccine Type– Revenue and Forecast to 2028 (USD Million)
10.4.6.3.3 Rest of South and Central America Plant-Based Vaccines Market, By Source – Revenue and Forecast to 2028 (USD Million)
10.4.6.3.4 Rest of South and Central America Plant-Based Vaccines Market, By Application – Revenue and Forecast to 2028 (USD Million)
10.5 Middle East & Africa: Plant-based Vaccines Market
10.5.1 Middle East & Africa: Plant-based Vaccines Market– Revenue and Forecast to 2028 (USD Million)
10.5.2 Middle East & Africa: Plant-based Vaccines Market, by Vaccine Type- Revenue and Forecast to 2028 (USD Million)
10.5.3 Middle East & Africa: Plant-based Vaccines Market, by Source - Revenue and Forecast to 2028 (USD Million)
10.5.4 Middle East & Africa: Plant-based Vaccines Market, by Application - Revenue and Forecast to 2028 (USD Million)
10.5.5 Middle East & Africa: Plant-based Vaccines Market, by Country, 2021& 2028 (%)
10.5.5.1 Saudi Arabia: Plant-based Vaccines Market– Revenue and Forecast to 2028 (USD Million)
10.5.5.1.1 Saudi Arabia: Plant-based Vaccines Market– Revenue and Forecast to 2028 (USD Million)
10.5.5.1.2 Saudi Arabia: Plant-based Vaccines Market, by Vaccine Type- Revenue and Forecast to 2028 (USD Million)
10.5.5.1.3 Saudi Arabia: Plant-based Vaccines Market, by Source - Revenue and Forecast to 2028 (USD Million)
10.5.5.1.4 Saudi Arabia: Plant-based Vaccines Market, by Application- Revenue and Forecast to 2028 (USD Million)
10.5.5.2 South Africa: Plant-based Vaccines Market- Revenue and Forecast to 2028 (USD Million)
10.5.5.2.1 South Africa: Plant-based Vaccines Market Market– Revenue and Forecast to 2028 (USD Million)
10.5.5.2.2 South Africa: Plant-based Vaccines Market, by Vaccine Type- Revenue and Forecast to 2028 (USD Million)
10.5.5.2.3 South Africa : Plant-based Vaccines Market, by Source - Revenue and Forecast to 2028 (USD Million)
10.5.5.2.4 South Africa: Plant-based Vaccines Market, by Application- Revenue and Forecast to 2028 (USD Million)
10.5.5.3 UAE: Plant-based Vaccines Market– Revenue and Forecast to 2028 (USD Million)
10.5.5.3.1 UAE: Plant-based Vaccines Market– Revenue and Forecast to 2028 (USD Million)
10.5.5.3.2 UAE: Plant-based Vaccines Market, by Vaccine Type- Revenue and Forecast to 2028 (USD Million)
10.5.5.3.3 UAE: Plant-based Vaccines Market, by Source- Revenue and Forecast to 2028 (USD Million)
10.5.5.3.4 UAE: Plant-based Vaccines Market, by Application- Revenue and Forecast to 2028 (USD Million)
10.5.5.4 Rest of Middle East & Africa: Plant-based Vaccines Market- Revenue and Forecast to 2028 (USD Million)
10.5.5.4.1 Rest of Middle East & Africa: Plant-based Vaccines Market– Revenue and Forecast to 2028 (USD Million)
10.5.5.4.2 Rest of Middle East & Africa: Plant-based Vaccines Market, by Vaccine Type- Revenue and Forecast to 2028 (USD Million)
10.5.5.4.3 Rest of Middle East & Africa: Plant-based Vaccines Market, by Source - Revenue and Forecast to 2028 (USD Million)
10.5.5.4.4 Rest of Middle East & Africa: Plant-based Vaccines Market, by Application- Revenue and Forecast to 2028 (USD Million)
11. Impact Of COVID-19 Pandemic On Global Plant-based Vaccines Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment of COVID-19 Pandemic
11.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
11.4 South and Central America: Impact Assessment of COVID-19 Pandemic
11.5 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
12. Plant-based Vaccines Market –Industry Landscape
12.1 Overview
12.2 Growth Strategies in the Plant-based Vaccines Market, 2019-2021
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. Company Profiles
13.1 MEDICAGO, INC.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 British American Tobacco p.l.c.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 ICON GENETICS GMBH
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
SWOT Analysis
13.3.5 Key Developments
13.4 CREATIVE BIOLABS, INC.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 iBio, Inc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 LENIOBIO
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Lumen Bioscience, Inc.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 LEAF EXPRESSION SYSTEMS LTD.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 ZYUS LIFE SCIENCES INC.
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 FRAUNHOFER CMB
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Plant-Based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
Table 2. North America Plant-Based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 3. North America Plant-Based Vaccines Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 4. US Plant-Based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
Table 5. US Plant-Based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 6. US Plant-Based Vaccines Devices Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 7. Canada Plant-Based Vaccines Market, by Vaccine Type -Revenue and Forecast to 2028 (USD Million)
Table 8. Canada Plant-Based Vaccines Market, by Source - Revenue and Forecast to 2028 (USD Million)
Table 9. Canada Plant-Based Vaccines Devices Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 10. Mexico Plant-Based Vaccines Market, by Vaccine Type -Revenue and Forecast to 2028 (USD Million)
Table 11. Mexico Plant-Based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 12. Mexico Plant-Based Vaccines Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 13. Europe: Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
Table 14. Europe: Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 15. Europe: Plant-based Vaccines Market, By Application – Revenue and Forecast to 2028 (USD Million)
Table 16. Germany: Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
Table 17. Germany: Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 18. Germany: Plant-based Vaccines Market, By Application – Revenue and Forecast to 2028 (USD Million).
Table 19. France: Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
Table 20. France: Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 21. France: Plant-based Vaccines Market, By Application – Revenue and Forecast to 2028 (USD Million).
Table 22. UK: Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
Table 23. UK: Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 24. UK: Plant-based Vaccines Market, By Application – Revenue and Forecast to 2028 (USD Million).
Table 25. Italy: Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
Table 26. Italy: Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 27. Italy: Plant-based Vaccines Market, By Application – Revenue and Forecast to 2028 (USD Million).
Table 28. Spain: Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
Table 29. Spain: Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 30. Spain: Plant-based Vaccines Market, By Application – Revenue and Forecast to 2028 (USD Million).
Table 31. Rest of Europe: Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
Table 32. Rest of Europe: Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 33. Rest of Europe: Plant-based Vaccines Market, By Application – Revenue and Forecast to 2028 (USD Million).
Table 34. Asia Pacific Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
Table 35. Asia Pacific Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 36. Asia Pacific Plant-based Vaccines Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 37. China Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
Table 38. China Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 39. China Plant-based Vaccines Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 40. Japan Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
Table 41. Japan Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 42. Japan Plant-based Vaccines Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 43. India Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
Table 44. India Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 45. India Plant-based Vaccines Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 46. South Korea Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
Table 47. South Korea Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 48. South Korea Plant-based Vaccines Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 49. Australia Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
Table 50. Australia Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 51. Australia Plant-based Vaccines Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 52. Rest of Asia Pacific Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
Table 53. Rest of Asia Pacific Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 54. Rest of Asia Pacific Plant-based Vaccines Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 55. South and Central America Plant-Based Vaccines Market, By vaccine Type– Revenue and Forecast to 2028 (USD Million)
Table 56. South and Central America Plant-Based Vaccines Market, By Source – Revenue and Forecast to 2028 (USD Million)
Table 57. South and Central America Plant-Based Vaccines Market, By Application – Revenue and Forecast to 2028 (USD Million)
Table 58. Brazil Plant-Based Vaccines Market, By Vaccine Type– Revenue and Forecast to 2028 (USD Million)
Table 59. Brazil Plant-Based Vaccines Market, By Source – Revenue and Forecast to 2028 (USD Million)
Table 60. Brazil Plant-Based Vaccines Market, By Application – Revenue and Forecast to 2028 (USD Million)
Table 61. Argentina Plant-Based Vaccines Market, By Vaccine Type– Revenue and Forecast to 2028 (USD Million)
Table 62. Argentina Plant-Based Vaccines Market, By Source – Revenue and Forecast to 2028 (USD Million)
Table 63. Argentina Plant-Based Vaccines Market, By Application – Revenue and Forecast to 2028 (USD Million)
Table 64. Rest of South and Central America Plant-Based Vaccines Market, By Vaccine Type– Revenue and Forecast to 2028 (USD Million)
Table 65. Rest of South and Central America Plant-Based Vaccines Market, By Source – Revenue and Forecast to 2028 (USD Million)
Table 66. Rest of South and Central America Plant-Based Vaccines Market, By Application – Revenue and Forecast to 2028 (USD Million)
Table 67. Middle East & Africa Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
Table 68. Middle East & Africa Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 69. Middle East & Africa Plant-based Vaccines Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 70. Saudi Arabia Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
Table 71. Saudi Arabia Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 72. Saudi Arabia Plant-based Vaccines Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 73. South Africa Apnea Diagnostics Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
Table 74. South Africa Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 75. South Africa Plant-based Vaccines Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 76. UAE Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
Table 77. UAE Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 78. UAE Plant-based Vaccines Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 79. Rest of Middle East & Africa Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
Table 80. Rest of Middle East & Africa Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 81. Rest of Middle East & Africa Plant-based Vaccines Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 82. Recent organic developments in the Plant-based Vaccines Market
Table 83. Glossary of Terms, plant-based vaccines devices market
LIST OF FIGURES
Figure 1. Plant-based Vaccines Market Segmentation
Figure 2. Plant-based Vaccines Market Segmentation, By Region
Figure 3. Global Plant-based Vaccines Market Overview
Figure 4. Bacterial Vaccines Held the Largest Share of the Vaccine Type Segment in Plant-based Vaccines Market
Figure 5. Asia Pacific to Show Significant Growth during Forecast Period
Figure 6. Plant-based Vaccines Market, by Geography (US$ Million)
Figure 7. Global Plant-based Vaccines Market – Leading Country Markets (US$ Million)
Figure 8. Global Plant-based Vaccines Market, Industry Landscape
Figure 9. North America PEST Analysis
Figure 10. Europe PEST Analysis
Figure 11. Asia Pacific PEST Analysis
Figure 12. Middle East and Africa PEST Analysis
Figure 13. South and Central America (SCAM) PEST Analysis
Figure 14. Plant-Based Vaccines Market Impact Analysis of Driver and Restraints
Figure 15. Global Plant-based Vaccines Market– Revenue Forecast and Analysis – 2020- 2028
Figure 16. Global Plant-based Vaccines Market – By Geography Forecast and Analysis – 2021- 2028
Figure 17. Market Positioning of Key Players in Global Plant-based Vaccines Market
Figure 18. Plant-based Vaccines Market Revenue Share, by Vaccine Type (2021 and 2028)
Figure 19. Bacterial Vaccines: Plant-based Vaccines Market - Revenue and Forecasts to 2028 (US$ Mn)
Figure 20. Viral Vaccines: Plant-based Vaccines Market - Revenue and Forecasts to 2028 (US$ Mn)
Figure 21. Parasite Vaccines: Plant-based Vaccines Market - Revenue and Forecasts to 2028 (US$ Mn)
Figure 22. Plant-derived Virus-like particles (VLPs): Plant-based Vaccines Market - Revenue and Forecasts to 2028 (US$ Mn)
Figure 23. Others: Plant-based Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Plant-based Vaccines Market Revenue Share, by Source (2021 and 2028)
Figure 25. Tobacco Plant: Plant-based Vaccines Market - Revenue and Forecasts to 2028 (US$ Mn)
Figure 26. Maize: Plant-based Vaccines Market - Revenue and Forecasts to 2028 (US$ Mn)
Figure 27. Potato: Plant-based Vaccines Market - Revenue and Forecasts to 2028 (US$ Mn)
Figure 28. Others: Plant-based Vaccines Market - Revenue and Forecasts to 2028 (US$ Mn)
Figure 29. Plant-based Vaccines Market Revenue Share, by Application (2021 and 2028)
Figure 30. Influenza: Plant-based Vaccines Market - Revenue and Forecasts to 2028 (US$ Mn)
Figure 31. Zika Virus: Plant-based Vaccines Market - Revenue and Forecasts to 2028 (US$ Mn)
Figure 32. Ebola Virus: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
Figure 33. Poultry Disease: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
Figure 34. Covid-19: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
Figure 35. Others: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
Figure 36. North America: Plant-Based Vaccines Market, by Key Country – Revenue (2021) (USD Million)
Figure 37. North America Plant-Based Vaccines Market Revenue and Forecast to 2028 (USD Million)
Figure 38. North America: Plant-Based Vaccines Market, by Country, 2021 & 2028 (%)
Figure 39. US: Plant-Based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
Figure 40. Canada: Plant-Based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
Figure 41. Mexico: Plant-Based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
Figure 42. Europe: Plant-based Vaccines Market, by Key Country – Revenue (2021) (USD Million)
Figure 43. Europe: Plant-based Vaccines Market Revenue and Forecast to 2028 (USD Million)
Figure 44. Europe: Plant-based Vaccines Market, by Country, 2021 & 2028 (%)
Figure 45. Germany: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
Figure 46. France: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
Figure 47. UK: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
Figure 48. Italy: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
Figure 49. Spain: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
Figure 50. Rest of Europe: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
Figure 51. Asia Pacific: Plant-based Vaccines Market, by Key Country – Revenue (2021) (USD Million)
Figure 52. Asia Pacific Plant-based Vaccines Market Revenue and Forecast to 2028 (USD Million)
Figure 53. Asia Pacific: Plant-based Vaccines Market, by Country, 2021 & 2028 (%)
Figure 54. China Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
Figure 55. Japan: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
Figure 56. India: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
Figure 57. South Korea: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
Figure 58. Australia: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
Figure 59. Rest of Asia Pacific: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
Figure 60. South and Central America: Plant-Based Vaccines Market, By Key Country – Revenue (2021) (USD Million)
Figure 61. South and Central America: Plant-Based Vaccines Market- Revenue and Forecasts To 2028 (USD Million)
Figure 62. South and Central America: Plant-Based Vaccines Market Share by Country – 2021 & 2028, (%)
Figure 63. Brazil: Plant-Based Vaccines Market- Revenue and Forecasts To 2028 (USD Million)
Figure 64. Argentina: Plant-Based Vaccines Market- Revenue and Forecasts To 2028 (USD Million)
Figure 65. Rest of South and Central America: Plant-Based Vaccines Market - Revenue and Forecast to 2028 (USD Million)
Figure 66. Middle East & Africa: Plant-based Vaccines Market, by Key Country – Revenue (2021) (USD Million)
Figure 67. Middle East & Africa Plant-based Vaccines Market Revenue and Forecast to 2028 (USD Million)
Figure 68. Middle East & Africa: Plant-based Vaccines Market, by Country, 2021& 2028 (%)
Figure 69. Saudi Arabia: Plant-based Vaccines Market– Revenue and Forecast to 2028 (USD Million)
Figure 70. South Africa: Plant-based Vaccines Market Market– Revenue and Forecast to 2028 (USD Million)
Figure 71. UAE: Plant-based Vaccines Market– Revenue and Forecast to 2028 (USD Million)
Figure 72. Rest of Middle East & Africa: Plant-based Vaccines Market– Revenue and Forecast to 2028 (USD Million)
Figure 73. Impact of COVID-19 Pandemic in North American Country Markets
Figure 74. Impact of COVID-19 Pandemic In European Country Markets
Figure 75. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
Figure 76. Impact Of COVID-19 Pandemic in South and Central America Africa Country Markets
Figure 77. Impact Of COVID-19 Pandemic in Middle East and Africa Country Markets
Figure 78. Growth Strategies in the Plant-based Vaccines Market, 2019-2021
The List of Companies - Plant-based Vaccines Market
- MEDICAGO, INC.
- British American Tobacco p.l.c.
- ICON GENETICS GMBH
- CREATIVE BIOLABS, INC.
- iBio, Inc.
- LENIOBIO
- Lumen Bioscience, Inc.
- LEAF EXPRESSION SYSTEMS LTD.
- ZYUS LIFE SCIENCES INC.
- FRAUNHOFER CMB
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the plant-based vaccines market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the global plant-based vaccines market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution